Last 7 days
-7.9%
Last 30 days
-12.4%
Last 90 days
-14.1%
Trailing 12 Months
-1.4%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-06 | Wirick Angela L | sold (taxes) | -297,081 | 57.23 | -5,191 | chief financial officer |
2023-08-04 | CARREL MICHAEL H | gifted | - | - | -1,250 | president, ceo, & director |
2023-07-26 | Dahlquist Karl S. | sold | -195,077 | 57.09 | -3,417 | chief legal officer |
2023-06-30 | Noznesky Justin J | acquired | 20,846 | 38.11 | 547 | chief mktg & strategy officer |
2023-06-30 | Seith Douglas J | acquired | 21,227 | 38.11 | 557 | chief operating officer |
2023-06-30 | Dahlquist Karl S. | acquired | 21,227 | 38.11 | 557 | chief legal officer |
2023-06-30 | CARREL MICHAEL H | acquired | 21,227 | 38.11 | 557 | president, ceo, & director |
2023-06-30 | Yount Deborah Lee | acquired | 17,149 | 38.11 | 450 | chief human resources officer |
2023-06-30 | Privitera Salvatore | acquired | 21,227 | 38.11 | 557 | chief technical officer |
2023-06-30 | Doraiswamy Vinayak | acquired | 21,227 | 38.11 | 557 | chief scientific officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-21 | Baystate Wealth Management LLC | unchanged | - | 775 | 4,837 | -% |
2023-09-20 | BARCLAYS PLC | reduced | -24.01 | -108,000 | 1,025,000 | -% |
2023-08-22 | COMERICA BANK | new | - | 96,000 | 96,000 | 0.01% |
2023-08-21 | OSAIC HOLDINGS, INC. | added | 0.78 | 113,035 | 677,630 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | added | 2.55 | 511,428 | 2,823,340 | -% |
2023-08-18 | Legato Capital Management LLC | added | 39.62 | 495,253 | 1,242,640 | 0.17% |
2023-08-17 | Orion Portfolio Solutions, LLC | reduced | -6.03 | 393,699 | 3,700,120 | 0.04% |
2023-08-16 | Nuveen Asset Management, LLC | added | 41.24 | 19,635,300 | 48,430,300 | 0.02% |
2023-08-15 | GOLDMAN SACHS GROUP INC | added | 10.07 | 3,065,170 | 12,927,600 | -% |
2023-08-15 | LAZARD ASSET MANAGEMENT LLC | unchanged | - | 14,000 | 89,000 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | alliancebernstein l.p. | 7.7% | 3,565,726 | SC 13G/A | |
Feb 14, 2023 | alger associates inc | 3.8% | 1,755,398 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.44% | 4,389,815 | SC 13G/A | |
Feb 03, 2023 | blackrock inc. | 8.0% | 3,735,766 | SC 13G/A | |
Feb 03, 2023 | invesco ltd. | 7.2% | 3,367,324 | SC 13G/A | |
Feb 14, 2022 | alger associates inc | 7.1% | 3,240,847 | SC 13G/A | |
Feb 14, 2022 | alliancebernstein l.p. | 7.5% | 3,455,856 | SC 13G | |
Feb 14, 2022 | price t rowe associates inc /md/ | 4.2% | 1,945,751 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 9.22% | 4,234,298 | SC 13G/A | |
Feb 09, 2022 | invesco ltd. | 5.3% | 2,437,617 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Aug 17, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 08, 2023 | 4 | Insider Trading | |
Aug 08, 2023 | 4 | Insider Trading | |
Jul 28, 2023 | 4 | Insider Trading | |
Jul 26, 2023 | S-8 | Employee Benefits Plan | |
Jul 26, 2023 | S-8 | Employee Benefits Plan | |
Jul 26, 2023 | 144 | Notice of Insider Sale Intent | |
Jul 26, 2023 | 10-Q | Quarterly Report | |
Jul 25, 2023 | 8-K | Current Report | |
Jul 03, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
SYK | 108.3B | 19.5B | 3.38% | 36.58% | 39.99 | 5.57 | 10.36% | 30.30% |
ISRG | 101.2B | 6.7B | -0.75% | 50.83% | 71.05 | 15.19 | 11.75% | -0.66% |
BSX | 77.5B | 13.4B | 6.45% | 36.39% | 85 | 5.78 | 8.69% | 3.17% |
BDX | 71.3B | 19.0B | -4.29% | 12.66% | 44.09 | 3.79 | 0.46% | -5.24% |
EW | 42.3B | 5.7B | -8.22% | -17.24% | 30.48 | 7.49 | 5.64% | -4.53% |
MID-CAP | ||||||||
PEN | 9.5B | 937.8M | -2.12% | 37.22% | 325.65 | 10.11 | 16.30% | 250.21% |
SWAV | 7.1B | 616.6M | -12.54% | -24.86% | 29.24 | 11.56 | 69.52% | 343.68% |
GMED | 5.1B | 1.1B | -6.10% | -12.07% | 24.23 | 4.65 | 12.63% | 50.85% |
IRTC | 2.6B | 452.1M | -21.20% | -33.94% | -26.32 | 5.78 | 24.99% | 24.09% |
TNDM | 1.3B | 790.3M | -27.09% | -56.49% | -5.97 | 1.69 | 3.21% | -1604.53% |
SMALL-CAP | ||||||||
ATEC | 1.6B | 421.8M | -15.15% | 56.11% | -9.32 | 3.69 | 44.49% | -2.43% |
AVNS | 947.4M | 780.7M | -7.75% | -9.65% | -26.32 | 1.21 | 4.68% | -510.17% |
CSII | 839.3M | 239.8M | 0.70% | 0.15% | -22.16 | 3.5 | -4.74% | -31.15% |
SILK | 609.7M | 162.9M | -27.67% | -61.65% | -11.53 | 3.74 | 42.67% | 12.82% |
14.4%
14.3%
3.1%
1.8%
90%
53.9%
37.7%
Y-axis is the maximum loss one would have experienced if AtriCure was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 4.7% | 365,686,000 | 349,297,000 | 330,379,000 | 315,569,000 | 302,783,000 | 289,630,000 | 274,329,000 | 258,836,000 | 243,133,000 | 212,581,000 | 206,531,000 | 210,127,000 | 211,984,000 | 230,066,000 | 230,807,000 | 222,379,000 | 215,706,000 | 208,602,000 | 201,630,000 | 194,799,000 | 187,008,000 |
Cost Of Revenue | 3.2% | 92,174,000 | 89,343,000 | 84,439,000 | 79,726,000 | 76,427,000 | 72,715,000 | 68,469,000 | 65,555,000 | 61,744,000 | 57,616,000 | 57,222,000 | 58,481,000 | 58,875,000 | 60,718,000 | 60,472,000 | 58,228,000 | 57,404,000 | 56,114,000 | 54,510,000 | 53,586,000 | 50,825,000 |
Gross Profit | 5.2% | 273,512,000 | 259,954,000 | 245,940,000 | 235,843,000 | 226,356,000 | 216,915,000 | 205,860,000 | 193,281,000 | 181,389,000 | 154,965,000 | 149,309,000 | 151,646,000 | 153,109,000 | 169,348,000 | 170,335,000 | 164,151,000 | 158,302,000 | 152,488,000 | 147,120,000 | 141,213,000 | 136,183,000 |
Operating Expenses | 1.4% | 298,297,000 | 294,255,000 | 288,609,000 | 286,878,000 | 167,999,000 | 159,975,000 | 150,655,000 | 143,077,000 | 233,845,000 | 199,629,000 | 193,542,000 | 193,702,000 | 199,811,000 | 212,604,000 | 203,457,000 | 184,554,000 | 176,116,000 | 165,505,000 | 164,247,000 | 157,868,000 | 153,637,000 |
S&GA Expenses | 0.6% | 236,615,000 | 235,220,000 | 231,272,000 | 229,481,000 | 222,087,000 | 216,657,000 | 204,649,000 | 200,611,000 | 184,295,000 | 152,240,000 | 150,829,000 | 153,131,000 | 159,854,000 | 172,879,000 | 167,143,000 | 147,965,000 | 141,125,000 | 131,663,000 | 129,524,000 | 123,879,000 | 120,238,000 |
R&D Expenses | 4.5% | 61,682,000 | 59,035,000 | 57,337,000 | 57,397,000 | 53,512,000 | 50,918,000 | 48,506,000 | 45,569,000 | 44,861,000 | 42,700,000 | 43,070,000 | 45,295,000 | 44,873,000 | 44,641,000 | 41,230,000 | 36,589,000 | 34,991,000 | 33,842,000 | 34,723,000 | 33,989,000 | 33,399,000 |
EBITDA | 100.0% | - | -23,480,000 | -33,155,000 | -43,590,000 | 65,748,000 | 64,420,000 | 62,839,000 | 58,241,000 | -43,920,000 | -43,681,000 | -43,156,000 | -40,677,000 | -45,130,000 | -41,349,000 | -30,884,000 | - | - | - | - | - | - |
EBITDA Margin | 100.0% | - | -0.07 | -0.10 | -0.14 | 0.22 | 0.22 | 0.23 | 0.23 | -0.18 | -0.21 | -0.21 | -0.19 | -0.21 | -0.18 | -0.13 | - | - | - | - | - | - |
Interest Expenses | 11.0% | 6,240,000 | 5,622,000 | 4,986,000 | 4,508,000 | 4,633,000 | 4,729,000 | 4,918,000 | 5,029,000 | 4,812,000 | 4,846,000 | 4,885,000 | 4,948,000 | 4,829,000 | 4,477,000 | 4,111,000 | 4,174,000 | 4,307,000 | 4,649,000 | 4,607,000 | 3,857,000 | 3,187,000 |
Earnings Before Taxes | 26.1% | -27,698,000 | -37,469,000 | -46,198,000 | -55,837,000 | 53,535,000 | 52,146,000 | 50,387,000 | 45,611,000 | -56,488,000 | -48,527,000 | -48,041,000 | -45,625,000 | -49,959,000 | -45,826,000 | -34,995,000 | -22,298,000 | -20,195,000 | -16,394,000 | -20,911,000 | -20,192,000 | -20,228,000 |
EBT Margin | 100.0% | - | -0.11 | -0.14 | -0.18 | 0.18 | 0.18 | 0.18 | 0.18 | -0.23 | -0.23 | -0.23 | -0.22 | -0.24 | -0.20 | -0.15 | - | - | - | - | - | - |
Net Income | 25.8% | -28,036,000 | -37,759,000 | -46,466,000 | -56,037,000 | 53,343,000 | 51,933,000 | 50,199,000 | 45,378,000 | -56,679,000 | -48,664,000 | -48,155,000 | -45,689,000 | -50,102,000 | -45,967,000 | -35,194,000 | -22,528,000 | -20,401,000 | -16,638,000 | -21,137,000 | -20,287,000 | -20,298,000 |
Net Income Margin | 100.0% | - | -0.11 | -0.14 | -0.18 | 0.18 | 0.18 | 0.18 | 0.18 | -0.23 | -0.23 | -0.23 | -0.22 | -0.24 | -0.20 | -0.15 | - | - | - | - | - | - |
Free Cashflow | 100.0% | - | -17,590,000 | -39,022,000 | -37,306,000 | -32,113,000 | -40,904,000 | -23,533,000 | -18,222,000 | -13,937,000 | -17,851,000 | -25,128,000 | -35,916,000 | -44,424,000 | -30,765,000 | -27,993,000 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 1.9% | 594 | 583 | 585 | 582 | 587 | 585 | 615 | 613 | 701 | 700 | 715 | 708 | 704 | 528 | 558 | 561 | 343 | 338 | 357 | 272 | 271 |
Current Assets | -0.1% | 238 | 238 | 215 | 212 | 206 | 200 | 196 | 196 | 236 | 298 | 307 | 296 | 292 | 127 | 143 | 138 | 147 | 155 | 175 | 88.00 | 87.00 |
Cash Equivalents | -13.1% | 67.00 | 77.00 | 58.00 | 49.00 | 55.00 | 28.00 | 44.00 | 40.00 | 68.00 | 85.00 | 42.00 | 33.00 | 89.00 | 22.00 | 28.00 | 33.00 | 25.00 | 21.00 | 32.00 | 18.00 | 14.00 |
Inventory | 13.4% | 55.00 | 49.00 | 46.00 | 44.00 | 41.00 | 41.00 | 39.00 | 39.00 | 38.00 | 36.00 | 35.00 | 34.00 | 33.00 | 32.00 | 29.00 | 28.00 | 24.00 | 24.00 | 22.00 | 22.00 | 22.00 |
Net PPE | - | - | - | - | 39.00 | 36.00 | 33.00 | 31.00 | 30.00 | 30.00 | 28.00 | 28.00 | 29.00 | 30.00 | 32.00 | 33.00 | 31.00 | 28.00 | 27.00 | 27.00 | 28.00 | 28.00 |
Goodwill | 0% | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 236 | 105 | 105 | 105 | 105 | 105 |
Liabilities | 2.7% | 132 | 128 | 129 | 132 | 131 | 122 | 132 | 125 | 316 | 309 | 302 | 290 | 287 | 300 | 311 | 303 | 102 | 99.00 | 107 | 108 | 111 |
Current Liabilities | 14.3% | 71.00 | 62.00 | 58.00 | 58.00 | 56.00 | 47.00 | 56.00 | 54.00 | 67.00 | 58.00 | 49.00 | 45.00 | 38.00 | 39.00 | 50.00 | 44.00 | 39.00 | 35.00 | 40.00 | 34.00 | 27.00 |
LT Debt, Non Current | -9.4% | 47.00 | 52.00 | 57.00 | 60.00 | 60.00 | 60.00 | 60.00 | 56.00 | 44.00 | 49.00 | 53.00 | 50.00 | 54.00 | 58.00 | 60.00 | 60.00 | 34.00 | 33.00 | 36.00 | 39.00 | 39.00 |
Shareholder's Equity | 1.7% | 462 | 455 | 457 | 450 | 457 | 463 | 484 | 488 | 385 | 391 | 412 | 418 | 417 | 227 | 247 | 258 | 242 | 239 | 249 | 164 | 160 |
Retained Earnings | -1.5% | -338 | -333 | -326 | -322 | -310 | -295 | -280 | -266 | -363 | -347 | -330 | -311 | -306 | -298 | -282 | -266 | -256 | -252 | -247 | -243 | -236 |
Additional Paid-In Capital | 1.5% | 803 | 791 | 787 | 778 | 771 | 762 | 765 | 755 | 749 | 738 | 742 | 729 | 724 | 526 | 530 | 525 | 498 | 492 | 497 | 407 | 396 |
Shares Outstanding | 0.2% | 47.00 | 47.00 | 47.00 | 46.00 | 46.00 | 46.00 | 46.00 | 45.00 | 45.00 | 45.00 | 45.00 | 44.00 | 40.00 | 39.00 | 40.00 | 38.00 | 37.00 | 37.00 | 34.00 | 34.00 | 33.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -76.7% | -2.81 | -1.59 | -22.14 | -21.89 | -20.33 | -29.10 | -13.78 | -10.13 | -6.08 | -13.10 | -19.87 | -27.35 | -33.75 | -18.46 | -15.81 | -11.30 | -3.49 | -8.18 | -4.17 | -3.63 | -8.71 |
Share Based Compensation | 4.8% | 32.00 | 30.00 | 29.00 | 29.00 | 29.00 | 29.00 | 28.00 | 27.00 | 26.00 | 25.00 | 23.00 | 21.00 | 20.00 | 18.00 | 18.00 | 18.00 | 18.00 | 17.00 | 16.00 | 15.00 | 15.00 |
Cashflow From Investing | -68.9% | 16.00 | 53.00 | 44.00 | 38.00 | 16.00 | -20.36 | 24.00 | 20.00 | -13.19 | -109 | -156 | -156 | -107 | 4.00 | -2.15 | -70.37 | -61.34 | -70.14 | -85.40 | -13.51 | -15.51 |
Cashflow From Financing | 54.5% | -0.95 | -2.08 | -7.06 | -6.53 | -8.39 | -7.43 | -7.64 | -3.70 | -1.74 | 187 | 189 | 184 | 205 | 16.00 | 14.00 | 97.00 | 76.00 | 78.00 | 100 | 16.00 | 17.00 |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Statement [Abstract] | ||||
Revenue | $ 100,918 | $ 84,529 | $ 194,412 | $ 159,105 |
Cost of revenue | 23,841 | 21,010 | 47,726 | 39,991 |
Gross profit | 77,077 | 63,519 | 146,686 | 119,114 |
Operating expenses: | ||||
Research and development expenses | 17,438 | 14,791 | 32,765 | 28,420 |
Selling, general and administrative expenses | 63,783 | 62,388 | 123,847 | 118,504 |
Total operating expenses | 81,221 | 77,179 | 156,612 | 146,924 |
Loss from operations | (4,144) | (13,660) | (9,926) | (27,810) |
Other income (expense): | ||||
Interest expense | (1,719) | (1,101) | (3,355) | (2,101) |
Interest income | 961 | 76 | 1,836 | 192 |
Other | (123) | (111) | 22 | (204) |
Loss before income tax expense | (5,025) | (14,796) | (11,423) | (29,923) |
Income tax expense | 93 | 45 | 171 | 101 |
Net loss | $ (5,118) | $ (14,841) | $ (11,594) | $ (30,024) |
Net (loss) income per share | ||||
Basic net loss per common share (in usd per share) | $ (0.11) | $ (0.32) | $ (0.25) | $ (0.66) |
Diluted net loss per common share (in usd per share) | $ (0.11) | $ (0.32) | $ (0.25) | $ (0.66) |
Weighted average shares outstanding | ||||
Weighted average shares outstanding—basic (in shares) | 46,266 | 45,692 | 46,187 | 45,610 |
Weighted average shares outstanding—diluted (in shares) | 46,266 | 45,692 | 46,187 | 45,610 |
Comprehensive income (loss): | ||||
Unrealized gain (loss) on investments | $ 427 | $ (449) | $ 1,468 | $ (2,788) |
Foreign currency translation adjustment | 36 | (430) | 19 | (608) |
Other comprehensive income (loss) | 463 | (879) | 1,487 | (3,396) |
Net loss | (5,118) | (14,841) | (11,594) | (30,024) |
Comprehensive loss, net of tax | $ (4,655) | $ (15,720) | $ (10,107) | $ (33,420) |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 67,240 | $ 58,099 |
Short-term investments | 59,785 | 63,014 |
Accounts receivable, less allowance for credit losses of $230 | 48,362 | 42,693 |
Inventories | 55,409 | 45,931 |
Prepaid and other current assets | 7,179 | 5,477 |
Total current assets | 237,975 | 215,214 |
Long-term investments | 7,598 | 51,509 |
Property and equipment, net | 40,540 | 38,833 |
Operating lease right-of-use assets | 4,353 | 3,787 |
Intangible assets, net | 67,383 | 39,339 |
Goodwill | 234,781 | 234,781 |
Other noncurrent assets | 1,541 | 1,985 |
Total assets | 594,171 | 585,448 |
Current liabilities: | ||
Accounts payable | 23,709 | 19,898 |
Accrued liabilities | 31,986 | 33,022 |
Current maturities of debt and leases | 15,715 | 5,472 |
Total current liabilities | 71,410 | 58,392 |
Long-term debt | 47,047 | 56,834 |
Finance lease liabilities | 8,614 | 9,147 |
Operating lease liabilities | 3,458 | 3,095 |
Other noncurrent liabilities | 1,220 | 1,226 |
Total liabilities | 131,749 | 128,694 |
Commitments and contingencies (Note 9) | ||
Stockholders’ Equity: | ||
Common stock, $0.001 par value, 90,000 shares authorized and 47,352 and 46,563 issued and outstanding | 47 | 47 |
Additional paid-in capital | 803,197 | 787,422 |
Accumulated other comprehensive loss | (2,609) | (4,096) |
Accumulated deficit | (338,213) | (326,619) |
Total stockholders’ equity | 462,422 | 456,754 |
Total liabilities and stockholders’ equity | $ 594,171 | $ 585,448 |